Nice Quarter from A...
Health Care: Drugs
Cyclacel Pharmaceuticals Inc. (CYCC: NASDAQ)
$0.60 -0.05 | -7.01%
02/10/12 - 03:59 PM ET
213.00K / 295.70K
Vol / Avg. Vol:0.65 / 0.65
Open / Prev. Close:0.60 - 0.65
Today's Range:0.36 - 1.84
52 Wk Range:9.54%
Performance YTD:TheStreet Rating:
Portfolios with CYCC
- Portfolio NameUser Type
- Contributor13 Biotech Stocks Bought an...
- ProWilbur Ross - Invesco Priva...
- Contributor10 Cheap Biotech Stocks Tha...
- Userjeezlola
- Contributor10 Biotech Stocks Expected ...
- UserJSD Holdings
- UserBesV Portfolio 1
- UserStock2009
- UserTdawg
- Userdgert86 Portfolio 1
Latest CYCC Headlines from TheStreet
- The Worst Biotech CEO of 2011 Is ... 12.09.11 | 07:12 am
- The Biotech Stock 13F Review: What Hedge Funds Were Buying and Selling 11.16.11 | 08:11 am
- Biotech Stock Mailbag: Somaxon, Transcept 10.07.11 | 06:10 am
- Biotech Stock Mailbag: Research Backs Shorting Micro-Cap Cancer Drug Stocks 09.30.11 | 05:09 am
- Biotech Stock Mailbag: Cyclacel Pharma 08.12.11 | 05:08 am
- Cyclacel Stock Gaps Down On Today's Open (CYCC) 08.08.11 | 10:08 am
- Biotech Stock Mailbag: Ranking Cheap Biotechs 07.01.11 | 08:07 am
- 10 Cheap Biotech Stocks That Could Soar 06.28.11 | 07:06 am
- ASCO: Traders Love Speculative Cancer Stocks 05.19.11 | 06:05 am
- Cyclacel Announces Abstracts Selected For Presentation At American Association For Cancer Research Annual Meeting 03.29.11 | 08:03 pm
Press Releases for CYCC
Partner Headlines for CYCC
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 11.18.11 | 09:11 am
- Buy And Sell Ideas Based On Wednesday's Big News And Price Decliners - Seeking Alpha 09.29.11 | 08:09 am
- The Biotech Bump: Cyclacel Pharmaceuticals - Benzinga 07.28.11 | 01:07 pm
- Profit From These 3 Analysts' Stock Picks for Under $10 - Seeking Alpha 07.13.11 | 09:07 am
- Cyclacel Pharmaceuticals Files S-3 $75M Mixed Securities Shelf - Benzinga 04.04.11 | 04:04 pm
- US scientists recreate heart defect in a lab dish - Reuters 02.09.11 | 01:02 pm
- Pfizer, Adolor End Collaboration to Develop Pain Meds: Biotech's Latest Troubles - Seeking Alpha 12.26.10 | 01:12 am
- UPDATE 2-Cyclacel says cancer compound fails mid-stage study - Reuters 12.21.10 | 01:12 pm
- UPDATE 1-Cyclacel says cancer compound fails mid-stage study - Reuters 12.21.10 | 11:12 am
